NCT05282251View on ClinicalTrials.gov

Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

July 15, 2024

Conditions
Lung Diseases
Interventions
DRUG

Intrapleural bupivacine nebulization

Intrapleural nebulization of bupivacine (10 ml of bupivacaine 0.5%) + Intravenous normal saline as a placebo

DRUG

Intravenous paracetamol and ketorolac

Intravenous analgesia: paracetamol (one gram) and Ketorolac (30 mg) + Intrapleural normal saline (10 ml) as a placebo

Trial Locations (1)

880

RECRUITING

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER